Lynx Therapeutics, Inc.
Records under this name other than patents Lynx Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Lynx Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,002,833 | Identifying Web Pages of the World Wide Web Relevant to a First File Based on a Relationship Tag Formerly held In force · Low confidence | In force | Low confidence | |
| US 7,790,418 | Isothermal Amplification of Nucleic Acids on a Solid Support Formerly held Term ended Term ended Nov 20, 2023 · High confidence | Term ended | Term ended Nov 20, 2023 | High confidence |
| US 7,972,820 | Isothermal Amplification of Nucleic Acids on a Solid Support Formerly held Term ended Term ended Dec 7, 2021 · Medium confidence | Term ended | Term ended Dec 7, 2021 | Medium confidence |
| US 6,653,077 | Method of screening for genetic polymorphism Formerly held Term ended Term ended Apr 30, 2021 · USPTO record | Term ended | Term ended Apr 30, 2021 | USPTO record |
| US 9,902,951 | Method of Nucleic Acid Amplification Formerly held Term ended Term ended May 2, 2020 · Medium confidence | Term ended | Term ended May 2, 2020 | Medium confidence |
| US 6,228,589 | Measurement of gene expression profiles in toxicity determination Formerly held Term ended Term ended Feb 28, 2020 · USPTO record | Term ended | Term ended Feb 28, 2020 | USPTO record |
| US 7,115,400 | Methods of Nucleic Acid Amplification and Sequencing Formerly held Term ended Ended no later than Sep 30, 2019 · Medium confidence | Term ended | Ended no later than Sep 30, 2019 | Medium confidence |
| US 10,370,652 | Methods of Nucleic acid amplification and sequencing Formerly held Term ended Term ended Sep 30, 2019 · Medium confidence | Term ended | Term ended Sep 30, 2019 | Medium confidence |
| US 6,699,660 | Immediate early genes and methods of use therefor Formerly held Term ended Term ended Jul 19, 2019 · USPTO record | Term ended | Term ended Jul 19, 2019 | USPTO record |
| US 7,985,565 | Method of Nucleic Acid Amplification Formerly held Term ended Term ended Jun 27, 2019 · Medium confidence | Term ended | Term ended Jun 27, 2019 | Medium confidence |